Cited by 235Cytokine Signaling Pathways and InteractionsNF-κB Signaling PathwaysGenomics and Chromatin Dynamics

Regulation of IL-6 in Immunity and Diseases

Tanaka, Toshio, Narazaki, Masashi, Masuda, Kazuya, Kishimoto, Tadamitsu·2016·Advances in Experimental Medicine and Biology

Abstract

Interleukin-6 (IL-6) is a prototypical cytokine with functional pleiotropy and plays an important role in host defense. When infections or tissue injuries occur, IL-6 is promptly produced by monocytes and macrophages and contributes to removal of infectious agents and restoration of damaged tissues through activation of immune, hematological, and acute-phase responses. Once stress is removed from the host, IL-6 synthesis ends, but uncontrolled excessive or persistent IL-6 production plays a pathological role in the development of various inflammatory diseases and cancers, indicating that IL-6 is a double-edged sword for the host. Thus, the proper IL-6 expression is very important for host defense and is strictly controlled by chromatin structure, transcriptional regulation, and posttranscriptional modification. Differentiation status of cells, various transcription factors, RNA-binding proteins, and microRNAs are involved in this process. Since it is assumed that dysregulation of any of these regulatory molecules may cause abnormal IL-6 expression in a particular disease, further elucidation of the factors and processes involved in IL-6 expression can be expected to facilitate to clarification of pathogenesis and to identification of novel target molecule(s) for specific diseases.

Integrity signals

Registry

Crossref · 10.1007/978-94-024-0921-5_4

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tanaka, T., Narazaki, M., Masuda, K., & Kishimoto, T.
Affiliations
The University of Osaka (JP)
Corresponding author
Kishimoto, Tadamitsu
Venue
Advances in Experimental Medicine and Biology
Published
2016
Volume
941
Pages
79-88
ISSN
  • 0065-2598 (ISSN-L)
  • 2214-8019
OpenAlex
W2531841653
Cited by
235
References
42
Citations by year
2026: 25 · 2025: 30 · 2024: 30 · 2023: 23 · 2022: 36 · 2021: 41 · 2020: 29 · 2019: 14 · 2018: 3 · 2017: 4
FWCI
17.38
Type
book chapter
Language
en
Open access
closed
Locations
  • Advances in experimental medicine and biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
interleukin-6, cytokine regulation, transcriptional regulation, post-transcriptional modification, chromatin structure, microRNA, RNA-binding proteins, transcription factors, monocytes, macrophages, acute phase response, inflammation, cancer, host defense
MeSH terms
Animals, Disease, Gene Expression Regulation, Humans, Immune System, Inflammation, Protein Processing, Post-Translational, Interleukin-6, RNA Interference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review